2006
DOI: 10.1016/j.jconrel.2005.11.014
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

15
148
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 366 publications
(163 citation statements)
references
References 55 publications
15
148
0
Order By: Relevance
“…However, at that time a steady state is achieved and no further release is observed up to 24h. This initial burst release might correspond to the amount of protein that is located at the surface of the nanoparticles, which thus easily desorbs, an effect that has been reported in other studies (Amidi et al, 2006). Other works available in the literature describe quite similar release behaviour.…”
Section: Preparation and Characterisation Of Nanoparticlessupporting
confidence: 68%
See 2 more Smart Citations
“…However, at that time a steady state is achieved and no further release is observed up to 24h. This initial burst release might correspond to the amount of protein that is located at the surface of the nanoparticles, which thus easily desorbs, an effect that has been reported in other studies (Amidi et al, 2006). Other works available in the literature describe quite similar release behaviour.…”
Section: Preparation and Characterisation Of Nanoparticlessupporting
confidence: 68%
“…Figure 3 shows the in vitro release of BSA in PBS pH 7.4, a medium that intends to resemble the environment of mucosal surfaces like the pulmonary (Walters, 2002), although in some cases it has also been used in the context of nasal delivery (Amidi et al, 2006;Amidi et al, 2007;Fernández-Urrusuno et al, 1999a). Results indicate that, for both formulations, the release of BSA from nanoparticles shows an initial burst, releasing approximately 30% of the encapsulated protein in 2h.…”
Section: Preparation and Characterisation Of Nanoparticlesmentioning
confidence: 99%
See 1 more Smart Citation
“…Besides, hemolysis of the PECs suspensions was always lower than 1% when tested against mouse RBC (Figure 3), clearly below the 5% value considered as the toxicity threshold. These results are in agreement with other reports on TMC based nanovectors with low toxicity 46 and also show a correlation of the cytotoxicity with other structural parameters besides surface charge, like size of the 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 nanoparticles, molecular weight of chitosan and acetylation degree. 47 Moreover, the lowered buffering capacity of chitosan after methylation 5 prevents endo-lysosomal disruption and scape, 48 which in combination with the dissociation capacity of the PECs at low pH 5 and the eventual TMC degradation by lysosomal enzymes, 49 may preserve lysosomal function after PECs internalization.…”
Section: Specific Enzymatic Activity and Activity In Primary Culturessupporting
confidence: 94%
“…Generally, size distributions with polydispersity indices of less than 0.1 are considered to be monodisperse. 36,37 Effect of ion identity, ionic strength, and pH on the self-association of peptibody A The PbA s w values (and hence self-association) were observed to be very sensitive to ionic strength as well as anion identity. For a fixed PbA concentration (1 mg/mL) and a given NaX (X ¼ halogen ion) concentration, the s w values increased with the atomic size of the monovalent anion [ Fig.…”
Section: Solution Behavior Of Peptibody Amentioning
confidence: 99%